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Schizophrenia is a multi-factorial disease characterized by a high heritability and
environmental risk factors. In recent years, an increasing number of researchers
worldwide have started investigating the “two-hit hypothesis” of schizophrenia predicting
that genetic and environmental risk factors (GxE) interactively cause the development of
the disorder. This work is starting to produce valuable new animal models and reveal novel
insights into the pathophysiology of schizophrenia. This mini review will focus on recent
advancements in the field made by challenging mutant and transgenic rodent models
for the schizophrenia candidate gene neuregulin 1 (NRG1) with particular environmental
factors. It will outline results obtained from mouse and rat models for various Nrg1
isoforms/isoform types (e.g., transmembrane domain Nrg1, Type II Nrg1), which have
been exposed to different forms of stress (acute versus chronic, restraint versus social)
and housing conditions (standard laboratory versus minimally enriched housing). These
studies suggest Nrg1 as a prime candidate for GxE interactions in schizophrenia rodent
models and that the use of rodent models will enable a better understanding of GxE
interactions and the underlying mechanisms.
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INTRODUCTION
The two-hit hypothesis of schizophrenia states that a combination
of genetic and environmental risk factors causes the development
of schizophrenia (Bayer et al., 1999; Rapoport et al., 2005; Caspi
and Moffitt, 2006). Indeed, twin studies show that nature and
nuture are both important in the development of schizophre-
nia (i.e., concordance rate of monozygotic twins is 50%) (Tsuang
et al., 2001) and combined actions of multiple genes of small
effect (Owen et al., 2005) and a number of environmental risk
factors (McGrath et al., 2004) is likely (Mackay-Sim et al., 2004).
Genome wide association studies suggest that it is important
to consider the interplay of genes and environment to under-
stand the aetiology of the disorder in more depth (Sanders
et al., 2008). In this context, interactions of genetic and envi-
ronmental risk factors (GxE) occur when an individual’s genetic
predispositions are expressed dependent on their environment or
when environmental influences on a trait differ according to the
individual’s genome (Tsuang et al., 2004). According to the neu-
rodevelopmental theory of schizophrenia genes and environment
together affect brain development negatively during critical peri-
ods of neuronal development and thereby induce schizophrenia
(Marenco andWeinberger, 2000).
Animal models can incorporate genetic and environmental
risk factors at different stages of development, thereby more
accurately mimicking the aetiology of schizophrenia, and help
elucidate interactions between those factors and underlying
mechanism (Burrows et al., 2011). For example, neuregulin 1
(NRG1) is a genetic target for schizophrenia research (Stefansson
et al., 2002; Tosato et al., 2005; Munafo et al., 2006) as it influences
key neurodevelopmental processes relevant to schizophrenia (e.g.,
myelination and neuronal migration), and regulates receptors
such as N-methyl-D-aspartic acid (NMDA) and γ-aminobutyric
acid receptor A (GABAA) (Mei and Xiong, 2008). It has been out-
lined that there might be genetic subgroups in the population
that are more vulnerable to particular environmental risk fac-
tors (e.g., cannabis abuse, developmental trauma) (van Os et al.,
2010) and NRG1 might be such a genetic candidate. This review
will summarize preclinical data to assess if Nrg1 might be medi-
ating an increased risk to environmental factors with relevance to
schizophrenia (i.e., stress and cannabis) and experimental animal
research (i.e., laboratory housing conditions).
Nrg1 X LABORATORY HOUSING
Environmental enrichment (EE) has a significant impact on ani-
mal models of neurodegenerative diseases (van Dellen et al., 2000;
Spires and Hannan, 2005). Furthermore, enriched cage struc-
tures can modify or even rescue knockout-specific abnormalities
of genetic mouse models (Rampon et al., 2000; van Dellen et al.,
2000). Thus, the behavioral effects of minimally enriched housing
(ME) compared to standard laboratory housing were determined
in male transmembrane domain Nrg1 mutant and wild type-
like control mice (Karl et al., 2007). This mutant mouse model
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has been shown to have compelling construct, face, and predic-
tive validity for schizophrenia (Stefansson et al., 2002; Walss-Bass
et al., 2006; Karl et al., 2007, 2011; van den Buuse et al., 2009;
Duffy et al., 2010; Chesworth et al., 2012a). Mice were tested at
the age of 3–4 and 4–6 months, as the age of patients has a signif-
icant impact on the aetiology of schizophrenia (Thompson et al.,
2004). Effects of Nrg1 mutation on locomotion, exploration and
anxiety-like behaviors were age-dependent and interacted with
the housing condition males were raised in. Nrg1 mutants kept
in ME developed hyper-exploration in the light-dark test and
reduced anxiety-like behavior in the open field test at 3–4 months
of age whereas Nrg1 males kept in standard housing displayed
these phenotypes only at the age of 4–6 months. Importantly,
well-known explorative and anxiolytic-like properties of cage
enrichment (Chapillon et al., 1999; Roy et al., 2001; Benaroya-
Milshtein et al., 2004) were more pronounced in Nrg1 mutant
mice than control mice suggesting that mutant transmembrane
domain Nrg1 increased the behavioral sensitivity to ME.
Nrg1 mutant mice are characterized by hypo-phosphorylation
of the NR2B subunit (Bjarnadottir et al., 2007). This is in line
with Nrg1’s up-regulation of NMDA subunits expression (Ozaki
et al., 1997; Stefansson et al., 2004) and the stimulation of
Y1472 phosphorylation on the NR2B subunit of NMDA recep-
tors. As NMDA antagonists induce increased locomotor activity
(Wong and Van Tol, 2003; Javitt and Coyle, 2004) and as mouse
models for NMDA receptors suggest an involvement of the glu-
tamatergic system in rodent hyperactivity (Smith et al., 1998;
Dulawa et al., 1999; Mohn et al., 1999; Zhuang et al., 2001),
hypo-phosphorylated NR2 subunits may be responsible for the
observed hyperactivity. Nonetheless, it should be noted that Hahn
and colleagues found that Nrg1 stimulation suppressed NMDA
receptor activation in the human prefrontal cortex (Hahn et al.,
2006). EE does not impact the behavioral susceptibility to NMDA
receptor antagonists, but mRNA expression of specific NMDA
receptor subunits was decreased in mice kept in enriched housing
(Grilli et al., 2009). This suggests that combined effects of mutant
Nrg1 and ME (i.e., additive GxE) might be responsible for the
earlier onset of hyperactivity.
Importantly, hypo-phosphorylation of NR2B subunits inNrg1
mutant mice might also support the activation of dopaminergic
pathways (Duncan et al., 1999; Kapur and Seeman, 2002) and
thereby contribute to their anxiolytic-like and hyper-locomotive
phenotype. Indeed, dopamine transporter deficient mice are not
only characterized by hyperactivity but also decreased anxiety-
like-like responses (Carpenter et al., 2012). In this context, it
is important to note that exposure to enriched housing affects
the dopaminergic system as enrichment increased the suscep-
tibility of rats to the behavioral and neurochemical effects of
amphetamine (Bowling et al., 1993) although another study
found reduced dopamine receptor 1 function as a consequence
of enriched housing (Del Arco et al., 2007). Further research
is needed to pinpoint the mechanisms underlying the differen-
tial potency of ME in Nrg1 mutant and control mice but an
involvement of dopaminergic and glutamatergic circuits is likely.
Other genetic mouse models of schizophrenia have been
reported to benefit from more complex enriched housing envi-
ronments (McOmish et al., 2008). Thus, the disease-related
phenotype-strengthening effects of ME in Nrg1 mice are inter-
esting and opposite to reports by others (van Dellen et al.,
2000; Olsson and Dahlborn, 2002; Spires and Hannan, 2005).
Nrg1/NRG1 has been described as being critical for how an organ-
ism responds and adapts to the environment (Stefansson et al.,
2004). Thus, the biological function of Nrg1 may dictate this dis-
ease phenotype-strengthening response to an enriched housing
environment, which is different to the effects normally described
for EE (i.e., reversing disease phenotypes).
Nrg1 X STRESS
Stressful life events and changes in HPA axis function are asso-
ciated with and precipitate the onset of psychiatric disorders
(Koenig et al., 2002; Walker et al., 2008). Furthermore, stress plays
a role in the development [e.g., behavioral sensitization: (van Os
et al., 2010)] and severity of psychotic symptoms (Corcoran et al.,
2003) and triggers relapse in schizophrenia patients (Hultman
et al., 1997). There appears to be a genetic component to stress
vulnerability in schizophrenia: schizophrenia patients are more
sensitive to stress (van Winkel et al., 2008), handle negative life
events more poorly (Horan et al., 2005), and show impaired cor-
tisol and HPA axis activity in stressful situations (van Venrooij
et al., 2010). Importantly, a NRG1 polymorphism interacts with
psychosocial stress thereby affecting reactivity to expressed emo-
tions in schizophrenia patients (Keri et al., 2009) and NRG1 also
interacts with job strain thereby increasing the risk of heart dis-
ease (Hintsanen et al., 2007). Furthermore, Nrg1 is expressed in
brain regions controlling stress reactivity (Chen, 2007). Thus, a
number of research teams have investigated the response of Nrg1
rodent models to models.
A first study investigated the behavioral and endocrine
response of male transmembrane domain Nrg1 mutant mice
to acute restraint stress before and after the onset of the
age-dependent hyper-locomotive phenotype (Chesworth et al.,
2012b). The suppressive effect of stress on locomotion was evi-
dent in all mice regardless of genotype or age. Surprisingly, older
Nrg1 mutants appeared insensitive to anxiety-like-related stress
effects in the open field (i.e., center locomotion). All mice dis-
played robust stress-induced increases in serum corticosterone,
although the response was more pronounced in young Nrg1
mutants compared to WT mice. The study suggested that there
is no pronounced effect of mutant transmembrane domain Nrg1
on the endocrine and behavioral effects of acute restraint stress.
Nevertheless, Nrg1modified corticosterone release in youngNrg1
mutants and the anxiety-like response of hyper-locomotive older
Nrg1 mice, confirming that the gene plays a role in how an organ-
ism responds to environmental manipulations. The phenomenon
of a disconnected behavioral and endocrine stress response of
older Nrg1 mice (i.e., no stress-induced anxiety-like response
in open field but increased glucocorticoid levels) is consistent
with other mouse models (Laarakker et al., 2011; Trainor et al.,
2011). Future research should address the impact of chronic stress
on Nrg1 mutant mice and consider additional aspects of HPA
functions.
Importantly, recent rat research suggests that Nrg1 might be
involved in stress reactivity downstream from the release of gluco-
corticoids (Taylor et al., 2011b). More specifically, a rat model for
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disrupted Type II Nrg1 expression was characterized by increased
baseline corticosterone levels and improved recovery of corticos-
terone levels post-acute restraint stress. Importantly, in control
rats, Type II Nrg1 was expressed in the neurocircuitry involved in
regulating HPA responses to environmental stimuli. The authors
concluded that disruptions to Type II Nrg1 expression mediated
an increased basal HPA axis activity. Elevated levels of glucocor-
ticoid (but not mineralocorticoid) receptors in the hippocampus
and pituitary glands of Nrg1 mutant rats under baseline condi-
tions could then result in a more pronounced negative feedback
loop thereby increasing the inhibition of HPA axis activity fol-
lowing acute restraint stress. Interestingly, shifts in the balance of
glucocorticoid and mineralocorticoid receptor levels in humans
can create a vulnerability to psychiatric disease, especially among
genetically predisposed individuals (De Kloet et al., 1998; Zhe
et al., 2008). The change in the endocrine stress response of
mutant Type II rats was accompanied by altered habituation to
an open field environment across test days (Taylor et al., 2011b).
Nrg1 is necessary for the establishment of excitatory synapses
in GABAergic interneurons and for the development of a bal-
anced excitatory/inhibitory tone in the brain (Ting et al., 2011).
As GABAergic mechanisms play a role in controlling HPA axis
function (Herman et al., 2004), Nrg1-induced changes to the
GABAergic system might present a potential mechanism for the
observations in Type II Nrg1 mutant rats.
In a follow-up study it was found that some of the behavioral
and brain characteristics of Nrg1 hypomorphic rats were highly
sex-specific (Taylor et al., 2011a). It should be noted that sex-
specificity in rodent models for Nrg1 is a common phenomenon
(O’Tuathaigh et al., 2006; Duffy et al., 2010; Chesworth et al.,
2012a) and is in line with gender effects reported for schizophre-
nia patients (Canuso and Pandina, 2007). Inconsistencies between
the stress response of the two investigated Nrg1 rodent mod-
els are most likely due to (1) species differences (Asan et al.,
2005), (2) differences in the restraint stress models used (rats
were habituated to the general stress procedure whereas mice were
naïve), and (3) the particular characteristics of theNrg1 mutation
[(Harrison and Law, 2006; Mei and Xiong, 2008); for overview
on Nrg1 rodent models see: (Duffy et al., 2008; Karl et al., 2011)].
Adding to the complexity of potential Nrg1-stress interactions
is a study reporting that Type III Nrg1 mutant mice display a
blunted increase in corticosterone release after mild acute stress
(Chen, 2007).
Adolescence is a period of heightened risk to develop
schizophrenia (Walker and Bollini, 2002; Costello et al., 2003;
Paus et al., 2008) as abnormal adolescent brain development
contributes to the aetiology of schizophrenia (Paus et al., 2008;
Walker et al., 2008). Furthermore, stress response-relevant neu-
ronal pathways develop during adolescence (Andersen et al., 2000;
Spear, 2000; Casey et al., 2008) and HPA axis plasticity appears
sensitive to adolescent stress exposure as well (Romeo et al., 2006).
Thus, it is important to assess interactions between Nrg1 and
stress also during adolescence.
Indeed, Taylor and co-workers investigated the effects of
chronic variable stress during adolescence on endocrine and
behavioral measures in adult Type II Nrg1 mutant rats (Taylor
et al., 2012). Sex-specific interactions between Nrg1 genotype and
adolescent stress were found. Stress during adolescence reduced
baseline corticosterone levels in female control but not mutant
rats. Furthermore, stress increased extinction of cued fear con-
ditioning but only in Nrg1 females. The authors concluded that
the findings represent a true Nrg1 x stress interaction and are
consistent with a reduction in sensitivity to environmental stim-
uli and novelty as described earlier (Taylor et al., 2011a,b).
However, Nrg1 females were the only group susceptible to the
effects of adolescent stress on fear extinction. In addition, most
earlier findings had been evident in male rats (Taylor et al.,
2011b), which failed to be affected by the adolescent stress model
chosen.
Social defeat stress models aspect of psychosocial stress
in humans, which has been found to interact with a sin-
gle nucleotide polymorphism of NRG1 to affect the reactiv-
ity of schizophrenia patients to expressed emotion (Keri et al.,
2009). Psychosocial stress might also contribute to the develop-
ment of schizophrenia via sensitization of the pro-inflammatory
immune response leading to excessive pro-inflammatory cytokine
release. Thus, researchers investigated behavioral and neuro-
physiological effects of adolescent repeated intermittent social
defeat in adult transmembrane domain Nrg1 mutant males
(Desbonnet et al., 2012) and found that Nrg1 modified the
effects of social defeat on several behavioral, immunological
and brain measures. For example, psychosocial stress diminished
the hyper-locomotive phenotype of Nrg1 mutant mice without
accompanying effects on control littermates. In addition, stress
had cognitive-impairing effects in Nrg1 mice only and decreased
sucrose preference (model for anhedonia) in control but not
mutant mice. Social defeat also altered the lipopolysaccharide
and concanavalin A-stimulated cytokine response of the spleen
in a genotype-specific manner (see study for details). In the
brain, stress decreased interleukin-beta mRNA levels in the pre-
frontal cortex of mutant mice only, whereas striatal interleukin-
beta was down-regulated in controls and up-regulated in Nrg1
mice. Finally, hippocampal BDNF mRNA levels were elevated in
control mice and reduced in mutant mice whereas tumor necro-
sis factor-alpha was up-regulated in Nrg1 mice only. Reduced
striatal BDNF levels might have been involved in the disrupt-
ing effects of social defeat stress on the spatial memory of
Nrg1 mutant mice (Almli et al., 2000). Importantly, Nrg1 can
interact with BDNF in regulating neuronal processes (Mei and
Xiong, 2008; Balu and Coyle, 2011), BDNF down-regulation
has been reported in schizophrenia (Weickert et al., 2003;
Favalli et al., 2012), and BDNF expression changes impact
on the sensitivity to social defeat stress (Berton et al., 2006;
Krishnan et al., 2007). The authors concluded that the expe-
rience of psychosocial stress during adolescence may trigger
further pathophysiological features that contribute to the devel-
opment of schizophrenia in individuals underlying NRG1 gene
abnormalities. The interactive nature of the effects of stress and
mutant Nrg1 resulted in cognitive deficits and an imbalance
in BDNF and immunological parameters. On the other side,
stress impacted positively on the hyper-locomotive phenotype
of Nrg1 mutant mice, outlining the complexity of GxE interac-
tions in schizophrenia and the need to look at specific disease
endophenotypes.
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In summary, research teams have started evaluating the role
of Nrg1 in the neuro-endocrine, behavioral, and immunolog-
ical response of mice to stress. Results so far are inconclusive
demanding that future research should focus on schizophrenia-
relevant stress models [similar to (Desbonnet et al., 2012)],
consider sex and age in experimental designs, and focus
on schizophrenia-like behaviors and disease-relevant brain
markers.
Nrg1 X CANNABIS
A review on the role of Nrg1 in GxE in schizophrenia would be
incomplete without mentioning the extensive mouse work on
Table 1 | Effects of environmental factors on rodent models for the schizophrenia candidate gene neuregulin 1.
Nrg1 × Laboratory housing (i.e., minimal enrichment)
Transmembrane domain Nrg1 mutant male mice
(Karl et al., 2007)
Minimal enrichment shifted the onset of the hyper-explorative and
anxiogenic phenotype of Nrg1 mice to 3–4 months of age compared to




Transmembrane domain Nrg1 mutant male mice
(Chesworth et al., 2012b)
No pronounced effect of Nrg1 on the endocrine and behavioral effects of
acute restraint stress—only subtle, age-dependent modification of
stress-induced corticosterone release and anxiety-like behaviors.
Acute restraint stress
Adult Type II Nrg1 mutant rats
(Taylor et al., 2011a,b)
Altered habituation to an open field environment in Nrg1 mutant rats.
Mutant Nrg1 resulted in increased baseline corticosterone levels and
improved recovery of those levels post stress.
Elevated baseline levels of glucocorticoid receptors in hippocampus and
pituitary glands. Results are highly sex-specific.
Chronic variable stress
Adolescent Type II Nrg1mutant rats
(Taylor et al., 2012)
Female Nrg1 rats displayed no stress-induced reduction in corticosterone
levels and showed increased extinction of cued fear conditioning (no such
effects in male Nrg1 mutants).
Social defeat stress
Transmembrane domain Nrg1 mutant mice
(Desbonnet et al., 2012)
Stress diminished hyper-locomotion and induced cognitive deficits in Nrg1
mutant mice without accompanying effects in control mice. Nrg1 mutant
mice were protected against anhedonic properties of social defeat.
The effects of stress on the cytokine response of mice were
genotype-dependent (for details see study).
Stress decreased interleukin-beta mRNA levels in the prefrontal cortex of
Nrg1 mice. Striatal interleukin-beta levels were reduced in control mice
and increased in Nrg1mice. Hippocampal BDNF mRNA levels were
elevated in control mice and reduced in mutant mice whereas tumor
necrosis factor-alpha was up-regulated in Nrg1 mice only.
Nrg1 × Cannabis reviewed in (Arnold et al., 2012; Karl and Arnold, 2013; Ng et al., 2013)
Acute treatment with 9-tetrahydrocannabinol (THC)
Adult transmembrane domain Nrg1 mutant mice
(Boucher et al., 2007a,b; Long et al., 2010)
Nrg1 mutants displayed a sex-dependent increased susceptibility to the
locomotion-suppressive effects of THC and showed improved prepulse
inhibition post THC treatment.
THC induced increased neuronal activity in the ventral part of the lateral
septum and greater activity in central nucleus of the amygdala and the
paraventricular nucleus of the hypothalamus in Nrg1 mutant mice.
Chronic treatment with CP55,940 (CP)
Adult transmembrane domain Nrg1 mutant male mice
(Boucher et al., 2011)
Nrg1 mutants developed a behavioral tolerance to CP-induced
hypothermia and hypolocomotion more rapidly, whereas the same mice
did not develop a tolerance to CPs anxiogenic effects.
Mutant mice showed a selectively increase in CP-induced FosB/FosB
expression in the ventral part of lateral septum.
Chronic THC treatment
Adolescent transmembrane domain Nrg1mutant male mice
(Long et al., 2013)
THC exacerbated hyperlocomotion 48h after THC withdrawal. Nrg1
mutant mice were more resistant to social withdrawal effects of THC.
THC promoted genotype-dependent effects on CB1, 5-HT2A and NMDA
receptor expression (see study for details).
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Nrg1 x cannabis interactions. As those studies have been
reviewed elsewhere (Arnold et al., 2012; Karl and Arnold,
2013; Ng et al., 2013), this section will only provide a brief
summary. It has long been established that cannabis is a com-
ponent/cumulative cause for the development of schizophrenia
(Arseneault et al., 2002, 2004) suggesting interactions with other
risk factors (D’Souza et al., 2009). Until recently, Catechol-O-
methyltransferase (COMT) was the only candidate for a possible
interaction between a genetic predisposition for schizophrenia
and heavy cannabis abuse [(Caspi et al., 2005; O’Tuathaigh et al.,
2010) but see also (Zammit et al., 2011)]. Comprehensive anal-
yses on Nrg1 x cannabis interactions in transmembrane domain
Nrg1 mutant mice suggest that Nrg1 increases the susceptibility
of an organism to the neuro-behavioral effects of cannabis as well
(Boucher et al., 2007a,b, 2011; Long et al., 2010, 2012, 2010). The
clinical relevance of this research has recently been highlighted by
a genetic study in African Americans, which discovered NRG1 as
a major candidate for the development of cannabis dependence
(Han et al., 2012).
CONCLUSIONS
Recent research utilizing genetic rodent models has revealed an
interactive relationship between Nrg1 and a variety of envi-
ronmental factors. These interactions appear to be complex
and sensitive to a number of subtle variables, but do exist
and justify the need for future research in this area (van
Os et al., 2010). Researchers should focus on models with
significant relevance to schizophrenia including, for example,
cannabis abuse (discussed above) and maternal immunization
(Ibi et al., 2010; Giovanoli et al., 2013) and consider not only
Nrg1 but also other genetic candidates for GxE interactions.
Importantly, the research into Nrg1xE outlined above suggests
that valid GxE mouse models will be very sensitive to the
laboratory environment and other potential test confounders
(e.g., age and sex) so that a high level of transparency and
standardization of test conditions across research sites will be
crucial.
Although the exact nature of Nrg1xE and their consequences
for schizophrenia have to be evaluated further, an involvement
of the GABAergic, glutamatergic and BDNF systems seems likely.
Importantly, environmental (risk) factors not always induced
adverse (i.e., disease phenotype-strengthening) effects in Nrg1
mutants, which should be taken into account when looking into
GxE interactions [for genotype-specific effects of environmen-
tal factors see also (Tucci et al., 2006; Valdar et al., 2006)]. The
findings on Nrg1xE summarized in Table 1 are in line with the
GxE theory, contribute to the understanding of the pathogenesis
of schizophrenia, and might eventually help with possible early
intervention programs. Importantly, recent discussions on the
appropriate statistical modeling of GxE interactions (van Winkel
et al., 2008; Zammit et al., 2010) as well as the limitations of ani-
malmodel research into schizophrenia (Ayhan et al., 2009) should
be considered for future work.
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